Advanced medical research has brought us to the point where many serious conditions can potentially be treated and even cured - with people who have essentially faced a lifetime of being incapacitated finally able to conduct normal lives. Many of these treatments are drug-based gene therapies–- but they come with an extremely high price tag. The latest example–and most expensive medication to date– is bluebird bio’s recently-approved $2.8 million gene therapy to treat a rare blood
Read More
gene therapy
FundamentalVR Raises $20M for VR Surgical Simulation Platform
What You Should Know:
- FundamentalVR has raised an additional $20M to significantly accelerate medical skill-transfer and increase surgical proficiency through its world-leading medical simulation platform, Fundamental Surgery.
- The funding was led by EQT Life Sciences investing from the LSP Health Economics Fund 2 and joined by prior investors Downing Ventures. The new investments follow a Series A round in October 2019 and bring the
Read More
What to Know About Gene Therapy
Gene therapy is making a world where cancer and AIDS can be cured, and a person can alter their genetic makeup, changing the direction of their own and their offspring's evolution in the process. However, the effects of gene therapy are long-lasting, and may impact both your and the health of your future children.
What Is Gene Therapy?
Utilizing a gene or genes to treat or cure a disease or medical condition is known as gene therapy. Gene therapy frequently involves replacing a
Read More
Kelonia Therapeutics Emerges with $50M to Deliver Precision Targeted Genetic Medicines
What You Should Know:
- Kelonia Therapeutics, a Boston-based biotech company focused on vivo gene delivery, launched with a $50 million in Series A funding to expand the benefit and reach of genetic medicines.
- Despite life-changing responses, existing gene therapies are highly complex, costly, and limited by complicated treatment paradigms, tractable therapeutic applications, and dose-limiting toxicities. By enabling precisely targeted, highly efficient, manufacturable “off-the-shelf” in
Read More
Why Cancer Registries are Part of America’s Fight for Racial Equality
According to a 2019 study in the Proceedings of the National Academy of Sciences, one in 1,000 Black males can expect to die at the hands of the police. Black males were also 2.5 times more likely to die during an encounter with police than white males. For some, those figures are staggering. For many others, they are reminders of the racial disparities that have existed for far too long in this country.
So, in 2020, when recent events have brought racial injustice back into the national
Read More
Cleveland Clinic Names Top 10 Medical Innovations For 2021
Cleveland Clinic’s top clinicians and researchers present the top 10 medical innovations transforming medical advancements and new awards to recognize healthcare innovation.
The list of breakthrough technologies was selected by a committee of Cleveland Clinic subject matter experts, led by Will Morris, M.D., executive medical director for Cleveland Clinic Innovations, and Akhil Saklecha, M.D., managing director of Cleveland Clinic Ventures.
Here is a look at the top 10 medical
Read More
Mission Bio Lands $70M to Expand Cancer Therapies With Single-Cell Multi-Omics Platform
What You Should Know:
- Mission Bio raises $70 million in Series C funding led by
Novo Growth to accelerate the development of cancer therapies with single-cell multi-omics.
- Mission Bio’s Tapestri Platform, the first single-cell platform capable of detecting DNA and protein changes simultaneously, gives a profound insight into the mutations that drive disease to accelerate the development of novel treatments and save patient lives.
Mission Bio,
Inc., a South San Francisco,
Read More
Novartis to Establish AI Innovation Lab, Taps Microsoft As Strategic AI & Data Science Partner
- Novartis to establish the Novaris AI innovation lab and has formed a strategic partnership with Microsoft as its AI and data science partner.
- AI Innovation lab will leverage Novartis datasets with Microsoft’s advanced AI solutions, the lab will aim to create new AI models and applications to transform medicine.
- Novartis and Microsoft's strategic alliance will focus on the two core objectives of AI Empowerment and AI Exploration.
Novartis announced the formation of
Read More
Akouos Raises $50M to Advance Precision Medicine for Hearing Disorders
Akouos, a Boston, MA-based precision genetic medicine company developing gene therapies that restore and preserve hearing has raised $50 million in Series A funding co-led by 5AM Ventures and New Enterprise Associates (NEA) with participation from existing investor Partners Innovation Fund and new investors Sofinnova Ventures, RA Capital Management and Novartis Venture Fund. The company plans to use the funding round to advance its lead program to first-in-human clinical trials and bolster its
Read More
Vineti Raises $33.5M to Accelerate Patient Access to Cell and Gene Therapies
Vineti, Inc., a San Francisco, CA-based software automation and analytics platform for cell and gene therapies has raised $33.5 million in Series B funding led by Canaan and DFJ, with participation from GE Ventures, Section 32, Casdin Capital, and LifeForce Capital, along with other undisclosed investors. The funding round will further advance the first cloud-based “platform of record” specifically built to move transformative new personalized therapies such as CAR-T cell therapy into mainstream
Read More
